Results 291 to 300 of about 94,066 (344)
Some of the next articles are maybe not open access.
Modern developments in germline pharmacogenomics for oncology prescribing
Ca-A Cancer Journal for Clinicians, 2022Natalie M Reizine, Peter H O'donnell
exaly
Drug-receptor interactions and drug design
Trends in Pharmacological Sciences, 1988openaire +2 more sources
Nanooncology: The future of cancer diagnosis and therapy
Ca-A Cancer Journal for Clinicians, 2013Sanjiv S Gambhir
exaly
Texas medicine, 1989
Designer drugs are synthetic analogs of substances with known psychoactive properties. These analogs are dangerous due to their direct pharmacological effects and the presence of toxic by-products that occur during synthesis. Three groups of designer drugs are reviewed (fentanyl, meperidine, and methamphetamine analogs), and their psychoactive effects ...
openaire +1 more source
Designer drugs are synthetic analogs of substances with known psychoactive properties. These analogs are dangerous due to their direct pharmacological effects and the presence of toxic by-products that occur during synthesis. Three groups of designer drugs are reviewed (fentanyl, meperidine, and methamphetamine analogs), and their psychoactive effects ...
openaire +1 more source
Application of Nanotechnology in Cancer Therapy and Imaging
Ca-A Cancer Journal for Clinicians, 2008Dong M Shin
exaly
Recent developments in esophageal adenocarcinoma
Ca-A Cancer Journal for Clinicians, 2013Jesper Lagergren, Pernilla Lagergren
exaly